Choose Category
COVID-19
Harvard Law, Bill of Health: Protecting the Vulnerable SUD Population During COVID-19
March 26, 2020Details concerning the additional challenges faced by the SUD (and OUD) population at this time, the positive ameliorative steps taken by federal, state, and local governments, and recommended additional steps that are needed.
COVID-19
Webinar: Federal and State Policy Levers to Maintain Access to MOUD During the COVID-19 Pandemic
March 26, 2020Join Jocelyn Guyer, MPA, and Jodi Manz, MSW, as they review emerging federal and state actions and opportunities (including case studies) to assist those with OUD through the COVID-19 pandemic.
—————————————————————
Recorded Webinar | Slides | Q&A
COVID-19
SAMHSA: COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance
March 19, 2020The Substance Abuse and Mental Health Services Administration (SAMHSA) is providing guidance to ensure that SUD treatment services are uninterrupted during the COVID-19 public health emergency.
COVID-19
Webinar: MOUD and the COVID-19 National Emergency Response
March 19, 2020Join Dr. Hannah Snyder, Jodi Manz, MSW, and Daniel McClughen, Esq. as they review key steps, fast evolving regulatory changes, and newly issued guidance around MOUD during the COVID-19 pandemic.
—————————————————————
Recorded Webinar | Slides | Q&A
COVID-19
SAMHSA: FAQ on the provision of methadone and buprenorphine for the treatment of OUD in the COVID-19 Emergency
March 19, 2020The Substance Abuse and Mental Health Services Administration (SAMHSA) has compiled an FAQ on prescribing MOUD during the COVID-19 pandemic.
COVID-19
SAMHSA: Opioid Treatment Program (OTP) Guidance
March 17, 2020The Substance Abuse and Mental Health Services Administration (SAMHSA) expands previous guidance to provide increased flexibility during the COVID-19 pandemic and affirms its commitment to supporting OTPs in any way possible during this time.